A review on synthesis of isoniazid derivatives and their biological properties

Ayushi Tripathi, Y. F. Nadaf, Dinesh Bilehal, Swarnagowri Nayak, Santosh L. Gaonkar

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Isoniazid is the most important heterocyclic moiety in organic and medicinal chemistry due to the presence of reactive site in the molecule, which extends its application in various fields. Isoniazid is the most important first-line drug used in the treatment of tuberculosis. The interesting molecular design of isoniazid makes them apt moieties in drug design. In this review, our aim is to summarize recent synthetic strategies and pharmacological properties of isoniazid derivatives.

Original languageEnglish
Pages (from-to)21-36
Number of pages16
JournalInternational Journal of Pharmaceutical Research
Volume11
Issue number1
DOIs
Publication statusPublished - 01-01-2019

Fingerprint

Isoniazid
Organic Chemistry
Pharmaceutical Chemistry
Drug Design
Catalytic Domain
Tuberculosis
Pharmacology
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Tripathi, Ayushi ; Nadaf, Y. F. ; Bilehal, Dinesh ; Nayak, Swarnagowri ; Gaonkar, Santosh L. / A review on synthesis of isoniazid derivatives and their biological properties. In: International Journal of Pharmaceutical Research. 2019 ; Vol. 11, No. 1. pp. 21-36.
@article{4de008e67c23456ba753859a728aafde,
title = "A review on synthesis of isoniazid derivatives and their biological properties",
abstract = "Isoniazid is the most important heterocyclic moiety in organic and medicinal chemistry due to the presence of reactive site in the molecule, which extends its application in various fields. Isoniazid is the most important first-line drug used in the treatment of tuberculosis. The interesting molecular design of isoniazid makes them apt moieties in drug design. In this review, our aim is to summarize recent synthetic strategies and pharmacological properties of isoniazid derivatives.",
author = "Ayushi Tripathi and Nadaf, {Y. F.} and Dinesh Bilehal and Swarnagowri Nayak and Gaonkar, {Santosh L.}",
year = "2019",
month = "1",
day = "1",
doi = "10.31838/ijpr/2019.11.01.007",
language = "English",
volume = "11",
pages = "21--36",
journal = "Journal of International Pharmaceutical Research",
issn = "0975-2366",
publisher = "Editorial office of Journal of International Pharmaceutical Research",
number = "1",

}

A review on synthesis of isoniazid derivatives and their biological properties. / Tripathi, Ayushi; Nadaf, Y. F.; Bilehal, Dinesh; Nayak, Swarnagowri; Gaonkar, Santosh L.

In: International Journal of Pharmaceutical Research, Vol. 11, No. 1, 01.01.2019, p. 21-36.

Research output: Contribution to journalReview article

TY - JOUR

T1 - A review on synthesis of isoniazid derivatives and their biological properties

AU - Tripathi, Ayushi

AU - Nadaf, Y. F.

AU - Bilehal, Dinesh

AU - Nayak, Swarnagowri

AU - Gaonkar, Santosh L.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Isoniazid is the most important heterocyclic moiety in organic and medicinal chemistry due to the presence of reactive site in the molecule, which extends its application in various fields. Isoniazid is the most important first-line drug used in the treatment of tuberculosis. The interesting molecular design of isoniazid makes them apt moieties in drug design. In this review, our aim is to summarize recent synthetic strategies and pharmacological properties of isoniazid derivatives.

AB - Isoniazid is the most important heterocyclic moiety in organic and medicinal chemistry due to the presence of reactive site in the molecule, which extends its application in various fields. Isoniazid is the most important first-line drug used in the treatment of tuberculosis. The interesting molecular design of isoniazid makes them apt moieties in drug design. In this review, our aim is to summarize recent synthetic strategies and pharmacological properties of isoniazid derivatives.

UR - http://www.scopus.com/inward/record.url?scp=85060890444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060890444&partnerID=8YFLogxK

U2 - 10.31838/ijpr/2019.11.01.007

DO - 10.31838/ijpr/2019.11.01.007

M3 - Review article

VL - 11

SP - 21

EP - 36

JO - Journal of International Pharmaceutical Research

JF - Journal of International Pharmaceutical Research

SN - 0975-2366

IS - 1

ER -